Insiders · MGTA

MGTA insider transactions

Magenta Therapeutics Inc. (MGTA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for MGTA

• 820d
  SEC Form 4 filed by Carr Edward

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 820d
  SEC Form 4 filed by Veness Adam M

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 820d
  SEC Form 4 filed by Randhawa Simrat

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 820d
  SEC Form 4 filed by Savitz Ryan

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 820d
  SEC Form 4 filed by Garcia Marino

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 822d
  Moulder Leon O Jr was granted 166,667 shares (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 822d
  Fairmount Funds Management Llc was granted 834,334 shares (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 822d
  Meng Lei was granted 1,500,000 shares (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 935d
  Fairmount Funds Management Llc bought $336,252 worth of shares (24,670 units at $13.63) (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 940d
  Fairmount Funds Management Llc bought $394,500 worth of shares (30,000 units at $13.15) (SEC Form 4)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 943d
  SEC Form 4: Randhawa Simrat bought $52,800 worth of shares (4,000 units at $13.20)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 947d
  SEC Form 4: Fairmount Funds Management Llc bought $396,000 worth of shares (30,000 units at $13.20)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 955d
  SEC Form 4 filed by Meng Lei

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 955d
  SEC Form 3: New insider Meng Lei claimed ownership of 1,217,554 shares

  3 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 955d
  SEC Form 4 filed by Violin Jonathan

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 955d
  SEC Form 4: Fairmount Funds Management Llc bought $271,680 worth of shares (24,254 units at $11.20)

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 955d
  SEC Form 4 filed by Lawton Alison Frances

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 955d
  SEC Form 4 filed by Soteropoulos Paula

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 955d
  SEC Form 4 filed by Mcgeorge Anne

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 955d
  SEC Form 4 filed by Moulder Leon O Jr

  4 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 955d
  SEC Form 3: New insider Fairmount Funds Management Llc claimed ownership of 1,819,579 shares

  3 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 955d
  SEC Form 3 filed by new insider Soteropoulos Paula

  3 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 955d
  SEC Form 3 filed by new insider Garcia Marino

  3 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 955d
  SEC Form 3 filed by new insider Randhawa Simrat

  3 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 955d
  SEC Form 3 filed by new insider Veness Adam M

  3 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 955d
  SEC Form 3 filed by new insider Carr Edward

  3 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 955d
  SEC Form 3 filed by new insider Violin Jonathan

  3 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 955d
  SEC Form 3: New insider Moulder Leon O Jr claimed ownership of 1,270,078 shares

  3 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 955d
  SEC Form 3 filed by new insider Savitz Ryan

  3 - Dianthus Therapeutics, Inc. /DE/ (0001690585) (Issuer)
• 1171d
  SEC Form 4: Third Rock Ventures Iv, L.P. sold $3,056,000 worth of shares (3,700,000 units at $0.83)

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1240d
  SEC Form 4: Beetham Thomas W. was granted 3,000 shares, increasing direct ownership by 18% to 19,897 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1240d
  SEC Form 4: Mahoney Stephen F. was granted 3,000 shares, increasing direct ownership by 21% to 17,264 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1240d
  SEC Form 4: Deardorf Caren was granted 3,000 shares, increasing direct ownership by 18% to 19,762 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1240d
  SEC Form 4: Gardner Jason was granted 3,000 shares, increasing direct ownership by 1% to 292,872 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1240d
  SEC Form 4: Stants Kristen was granted 3,000 shares, increasing direct ownership by 17% to 20,264 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1348d
  SEC Form 4 filed by Vasconcelles Michael

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1348d
  SEC Form 3 filed by new insider Vasconcelles Michael

  3 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1363d
  SEC Form 4 filed by Olson Lisa

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1363d
  SEC Form 4 filed by Humphrey Jeffrey

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1363d
  SEC Form 4 filed by Beetham Thomas W.

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1363d
  SEC Form 4 filed by Gardner Jason

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1363d
  SEC Form 4 filed by Nichols David Wayne

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1363d
  SEC Form 4 filed by Mahoney Stephen F.

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1363d
  SEC Form 4 filed by Stants Kristen

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1363d
  SEC Form 4 filed by Deardorf Caren

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1395d
  SEC Form 4 filed by Booth Bruce

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1395d
  SEC Form 4 filed by Daniel Thomas O

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1395d
  SEC Form 4 filed by Lawton Alison Frances

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1395d
  SEC Form 4 filed by Ronneberg Amy L

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1395d
  SEC Form 4 filed by Albers Jeffrey W.

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1395d
  SEC Form 4 filed by Scadden David

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1395d
  SEC Form 4 filed by Mcgeorge Anne

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1419d
  SEC Form 4: Stants Kristen was granted 3,000 shares, increasing direct ownership by 21% to 17,264 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1419d
  SEC Form 4: Gardner Jason was granted 3,000 shares, increasing direct ownership by 1% to 289,872 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1419d
  SEC Form 4: Deardorf Caren was granted 3,000 shares, increasing direct ownership by 22% to 16,762 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1419d
  SEC Form 4: Beetham Thomas W. was granted 3,000 shares, increasing direct ownership by 22% to 16,897 units

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1437d
  SEC Form 4 filed by Olson Lisa

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1437d
  SEC Form 4 filed by Gardner Jason

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1437d
  SEC Form 4 filed by Humphrey Jeffrey

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)
• 1437d
  SEC Form 4 filed by Stants Kristen

  4 - Magenta Therapeutics, Inc. (0001690585) (Issuer)